Literature DB >> 3223925

Synthesis and properties of peptidyl derivatives of arginylfluoromethanes.

H Angliker1, P Wikström, P Rauber, S Stone, E Shaw.   

Abstract

Two peptide derivatives of arginylfluoromethane (Arg-CH2F), namely Bz(benzoyl)-Phe-ArgCH2F and D-Phe-Pro-Arg-CH2F, have been synthesized by extension of available methods, i.e. the Dakin-West reaction [Rasnick (1985) Anal. Biochem. 149, 461-465] or synthesis of a phthaloyl-blocked C-terminal fluoromethane [Rauber, Angliker, Walker & Shaw (1986) Biochem. J. 239, 633-640; Angliker, Wikström, Rauber & Shaw (1987) Biochem. J. 241, 871-875] with subsequent elongation. The guanidino group of arginine was protected as the bis-Cbz (benzyloxycarbonyl) derivative. The products were examined as active-site-directed inhibitors of some trypsin-related serine proteinases as well as a pair of cysteine proteinases. The results extend previous observations that the rate of alkylation of serine proteinases by fluoromethanes may be considerably slower than by chloromethanes. As expected, the amino acid sequence of the inhibitors influenced their relative effectiveness. Thus the rate of inactivation of a number of trypsin-like proteinases by D-Phe-Pro-Arg-CH2F varied by more than two orders of magnitude.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3223925      PMCID: PMC1135435          DOI: 10.1042/bj2560481

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

2.  Thiobenzyl benzyloxycarbonyl-L-lysinate, substrate for a sensitive colorimetric assay for trypsin-like enzymes.

Authors:  G D Green; E Shaw
Journal:  Anal Biochem       Date:  1979-03       Impact factor: 3.365

3.  Further observations on substrate-derived chloromethyl ketones that inactivate trypsin.

Authors:  E Shaw; G Glover
Journal:  Arch Biochem Biophys       Date:  1970-08       Impact factor: 4.013

4.  Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.

Authors:  C Kettner; E Shaw
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 5.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  In vivo studies of a synthetic inhibitor of thrombin.

Authors:  D Collen; O Matsuo; J M Stassen; C Kettner; E Shaw
Journal:  J Lab Clin Med       Date:  1982-01

7.  Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases.

Authors:  G D Green; E Shaw
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

8.  Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.

Authors:  C Kettner; E Shaw
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

9.  Active site mapping of human and rat urinary kallikreins by peptidyl chloromethyl ketones.

Authors:  C Kettner; C Mirabelli; J V Pierce; E Shaw
Journal:  Arch Biochem Biophys       Date:  1980-07       Impact factor: 4.013

10.  D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin.

Authors:  C Kettner; E Shaw
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

View more
  10 in total

1.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Reactivity versus steric effects in fluorinated ketones as esterase inhibitors: a quantum mechanical and molecular dynamics study.

Authors:  Josep Rayo; Lourdes Muñoz; Gloria Rosell; Bruce D Hammock; Angel Guerrero; F Javier Luque; Ramon Pouplana
Journal:  J Mol Model       Date:  2010-07-31       Impact factor: 1.810

3.  Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.

Authors:  P J Rosenthal; W S Wollish; J T Palmer; D Rasnick
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

4.  Pseudoarginine: synthesis and properties of derivatives of delta-(1-imidazolyl)norvaline.

Authors:  H Angliker; P Wikström; E Shaw
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

5.  Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.

Authors:  Erik I Tucker; Ulla M Marzec; Tara C White; Sawan Hurst; Sandra Rugonyi; Owen J T McCarty; David Gailani; András Gruber; Stephen R Hanson
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

6.  The synthesis of arginylfluoroalkanes, their inhibition of trypsin and blood-coagulation serine proteinases and their anticoagulant activity.

Authors:  T Ueda; C M Kam; J C Powers
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

7.  Affinity labelling of the Ca(2+)-activated neutral proteinase (calpain) in intact human platelets.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

Review 8.  Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.

Authors:  Marton Siklos; Manel BenAissa; Gregory R J Thatcher
Journal:  Acta Pharm Sin B       Date:  2015-09-26       Impact factor: 11.413

9.  Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors.

Authors:  Maciej Purwin; Agnieszka Markowska; Irena Bruzgo; Tomasz Rusak; Arkadiusz Surażyński; Urszula Jaworowska; Krystyna Midura-Nowaczek
Journal:  Int J Pept Res Ther       Date:  2016-09-19       Impact factor: 1.931

10.  An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.

Authors:  Jiang Yin; Maia M Cherney; Ernst M Bergmann; Jianmin Zhang; Carly Huitema; Hanna Pettersson; Lindsay D Eltis; John C Vederas; Michael N G James
Journal:  J Mol Biol       Date:  2006-07-07       Impact factor: 5.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.